Back to results
Not yet recruitingPhase 1

Phase 1 Study to Evaluate the Safety and Tolerability of 8M2D in Healthy People and Alzheimer's Patients

NCT07568041

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Contact

Kimberly Schafer, MS

619-912-7475kims@cennabiosciences.com
View on ClinicalTrials.gov
Phase 1 Study to Evaluate the Safety and Tolerability of 8M2D in Healthy People and Alzheimer's Patients — TrialFind